Skip to main content

Ardelyx, Inc.

ARDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001437402

In the last 90 days, Ardelyx, Inc. insiders filed 0 open-market purchases and 9 sales; 250 institutions reported holding it in 13F filings for Q2 2026, worth $906.4M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Ardelyx, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
9 filings
8 insiders, $697.1K in total
Insiders trading
8
Net value
−$697.1K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Ardelyx, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Ardelyx, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Hohenleitner SusanChief Financial Officer227,520Aug 25, 20264
Reilly Joseph JamesSee Remarks145,854Aug 25, 20265
Bishop John ESee Remarks317,095Aug 25, 20264
Brady James ParkerChief Human Resources Officer245,930Aug 25, 20264
Foster Eric DuaneChief Commercial Officer409,410Aug 25, 20265
Kelliher MikeChief Business Officer349,660Aug 25, 20265
Williams Laura AChief Patient Officer367,456Aug 25, 20267
Raab MichaelPresident & CEO1,619,792Aug 25, 202611
Mott David MDirector3,349,655Jun 18, 20262
Bertrand William C JRDirector329,507Jun 18, 20261
Rodgers Richard JDirector439,998Jun 18, 20261
Bazemore Robert BDirector68,006Jun 18, 20261
Parsey MerdadDirector83,746Jun 18, 20261
Cadoret-Manier OnaizaDirector178,156Jun 18, 20261
Bhanji MunaDirector163,808Jun 18, 20261
Grammer Elizabeth ASee Remarks299,895Nov 25, 20251
Renz Justin AChief Financial Officer409,052Aug 25, 20250
Rosenbaum David P.Chief Development Officer151,373IndirectNov 22, 20240
Blanks RobertSee Remarks314,421Nov 22, 20240
Felsch Robert OraSee Remarks91,560Aug 22, 20240
Rodriguez SusanChief Commercial Officer449,092May 23, 20240
Lundberg Jan MDirector146,794Jun 16, 20230
Block Geoffrey A.Director–Jun 16, 20230
Sandell Scott D10% Owner2,258,850IndirectDec 27, 20210
Baskett Forest10% Owner2,258,850IndirectDec 27, 20210
Jacobs Jeffrey WChief Scientific Officer119,483Nov 24, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 25, 2026 (view filing)7:19 PM ETAug 214 daysHohenleitner SusanChief Financial OfficerSSale−1.56K$3.86−$6.01K−0.7%227.5K after
Aug 25, 2026 (view filing)7:17 PM ETAug 214 daysReilly Joseph JamesSee RemarksSSale−3.98K$3.86−$15.4K−2.7%145.9K after2 lots
Aug 25, 2026 (view filing)7:16 PM ETAug 214 daysBishop John ESee RemarksSSale−19.8K$3.86−$76.2K−5.9%317.1K after2 lots
Aug 25, 2026 (view filing)7:15 PM ETAug 214 daysBrady James ParkerChief Human Resources OfficerSSale−15.1K$3.86−$58.4K−5.8%245.9K after2 lots
Aug 25, 2026 (view filing)7:13 PM ETAug 214 daysFoster Eric DuaneChief Commercial OfficerSSale−8.56K$3.86−$33.0K−2.0%409.4K after3 lots
Aug 25, 2026 (view filing)7:11 PM ETAug 214 daysKelliher MikeChief Business OfficerSSale−7.76K$3.86−$29.9K−2.2%349.7K after3 lots
Aug 25, 2026 (view filing)7:09 PM ETAug 214 daysWilliams Laura AChief Patient OfficerSSale−10.7K$3.86−$41.4K−2.8%367.5K after4 lots
Aug 25, 2026 (view filing)7:07 PM ETAug 214 daysRaab MichaelPresident & CEOSSale−58.6K$3.86−$225.9K−3.5%1.62M after4 lots
Jul 17, 2026 (view filing)4:09 PM ETJul 152 daysRaab MichaelPresident & CEOSSale−41.7K$5.06−$210.9K−2.4%1.68M after10b5-1
Jun 22, 2026 (view filing)Jun 184 daysWilliams Laura AChief Patient OfficerSSale−81.9K$5.99−$490.6K−17.8%378.2K after10b5-1
Jun 17, 2026 (view filing)Jun 152 daysRaab MichaelPresident & CEOSSale−41.7K$5.67−$236.2K−2.4%1.70M after10b5-1
May 22, 2026 (view filing)May 211 dayHohenleitner SusanChief Financial OfficerSSale−1.46K$6.27−$9.12K−0.6%229.1K after
May 22, 2026 (view filing)May 211 dayBrady James ParkerChief Human Resources OfficerSSale−1.85K$6.27−$11.6K−0.7%261.1K after
May 22, 2026 (view filing)May 211 dayReilly Joseph JamesSee RemarksSSale−3.72K$6.27−$23.3K−2.4%149.8K after2 lots
May 22, 2026 (view filing)May 211 dayFoster Eric DuaneChief Commercial OfficerSSale−8.00K$6.27−$50.1K−1.9%418.0K after3 lots
May 22, 2026 (view filing)May 211 dayKelliher MikeChief Business OfficerSSale−7.25K$6.27−$45.4K−2.0%357.4K after3 lots
May 22, 2026 (view filing)May 211 dayWilliams Laura AChief Patient OfficerSSale−6.99K$6.27−$43.8K−1.6%429.1K after4 lots
May 22, 2026 (view filing)May 211 dayRaab MichaelPresident & CEOSSale−54.7K$6.27−$343.3K−3.1%1.72M after4 lots
May 22, 2026 (view filing)May 211 dayBishop John ESee RemarksSSale−2.31K$6.27−$14.5K−0.7%336.8K after
May 19, 2026 (view filing)May 154 daysRaab MichaelPresident & CEOSSale−41.7K$6.28−$261.7K−2.3%1.77M after10b5-1
Apr 17, 2026 (view filing)Apr 152 daysRaab MichaelPresident & CEOSSale−41.7K$6.29−$262.1K−2.3%1.80M after10b5-1
Mar 18, 2026 (view filing)Mar 162 daysRaab MichaelPresident & CEOSSale−41.7K$5.84−$243.3K−2.2%1.82M after10b5-1
Feb 25, 2026 (view filing)Feb 241 dayRaab MichaelPresident & CEOSSale−41.7K$6.26−$260.8K−2.2%1.84M after10b5-1
Feb 23, 2026 (view filing)Feb 203 daysMott David MDirectorPPurchase+333.3K$5.84+$1.95M+11.2%3.30M after
Feb 23, 2026 (view filing)Feb 203 daysBishop John ESee RemarksSSale−3.18K$5.85−$18.6K−0.9%339.2K after3 lots
Feb 23, 2026 (view filing)Feb 203 daysReilly Joseph JamesSee RemarksSSale−4.99K$5.85−$29.2K−3.2%151.8K after3 lots
Feb 23, 2026 (view filing)Feb 203 daysWilliams Laura ASee RemarksSSale−8.18K$5.85−$47.8K−1.8%436.1K after2 lots
Feb 23, 2026 (view filing)Feb 203 daysHohenleitner SusanChief Financial OfficerSSale−2.03K$5.85−$11.9K−0.9%230.5K after2 lots
Feb 23, 2026 (view filing)Feb 203 daysBrady James ParkerChief Human Resources OfficerSSale−2.54K$5.85−$14.9K−1.0%262.9K after2 lots
Feb 23, 2026 (view filing)Feb 203 daysKelliher MikeSee RemarksSSale−9.60K$5.85−$56.1K−2.6%364.7K after3 lots
Feb 23, 2026 (view filing)Feb 203 daysRaab MichaelPresident & CEOSSale−46.0K$5.85−$269.0K−2.4%1.86M after5 lots
Feb 23, 2026 (view filing)Feb 203 daysFoster Eric DuaneChief Commercial OfficerSSale−10.4K$5.85−$61.1K−2.4%426.0K after4 lots
Jan 9, 2026 (view filing)Jan 81 dayWilliams Laura AChief Patient OfficerSSale−50.0K$6.98−$349.0K−12.1%361.6K after10b5-1
Nov 25, 2025 (view filing)Nov 214 daysGrammer Elizabeth ASee RemarksSSale−6.00K$5.54−$33.2K−2.0%299.9K after
Nov 25, 2025 (view filing)Nov 214 daysRaab MichaelPresident & CEOSSale−46.9K$5.54−$259.8K−3.1%1.46M after
Nov 25, 2025 (view filing)Nov 214 daysKelliher MikeSee RemarksSSale−5.56K$5.54−$30.8K−2.0%271.2K after
Nov 25, 2025 (view filing)Nov 214 daysWilliams Laura AChief Patient OfficerSSale−6.43K$5.54−$35.6K−1.8%359.9K after
Nov 25, 2025 (view filing)Nov 214 daysFoster Eric DuaneChief Commercial OfficerSSale−5.81K$5.54−$32.2K−1.9%295.7K after
Nov 25, 2025 (view filing)Nov 214 daysReilly Joseph JamesSee RemarksSSale−11.1K$5.54−$61.4K−9.2%108.9K after
Aug 28, 2025 (view filing)Aug 262 daysWilliams Laura AChief Patient OfficerSSale−80.0K$6.12−$489.6K−17.9%366.3K after2 lots10b5-1
Aug 28, 2025 (view filing)Aug 217 daysLateKelliher MikeChief Business OfficerSSale−5.42K$5.93−$32.1K−1.9%276.7K after
Aug 25, 2025 (view filing)Aug 214 daysWilliams Laura AChief Patient OfficerSSale−6.26K$5.93−$37.1K−1.6%396.3K after
Aug 25, 2025 (view filing)Aug 214 daysRenz Justin AChief Financial OfficerSSale−7.04K$5.93−$41.7K−1.7%409.1K after
Aug 25, 2025 (view filing)Aug 214 daysRaab MichaelPresident & CEOSSale−45.7K$5.93−$270.9K−3.0%1.50M after
Aug 25, 2025 (view filing)Aug 214 daysGrammer Elizabeth ASee RemarksSSale−5.84K$5.93−$34.6K−1.9%305.9K after
Aug 25, 2025 (view filing)Aug 214 daysFoster Eric DuaneChief Commercial OfficerSSale−15.3K$5.93−$90.8K−4.8%301.5K after
Jun 18, 2025 (view filing)Jun 162 daysMott David MDirectorPPurchase+200.0K$3.63+$726.0K+7.4%2.90M after
Jun 11, 2025 (view filing)Jun 92 daysMott David MDirectorPPurchase+200.0K$3.69+$738.0K+8.0%2.70M after
May 22, 2025 (view filing)May 202 daysWilliams Laura AChief Medical OfficerSSale−6.42K$4.08−$26.2K−1.6%402.6K after
May 22, 2025 (view filing)May 202 daysRenz Justin AChief Financial OfficerSSale−7.22K$4.08−$29.4K−1.7%416.1K after